Parenteral paclitaxel in a stable non-toxic formulation

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/335 (2006.01) A61K 9/107 (2006.01) A61K 31/337 (2006.01) A61K 47/10 (2006.01) A61K 47/18 (2006.01)

Patent

CA 2259297

Disclosed is a stable and effective formulation of a taxane analog, preferably paclitaxel. The formulation comprises a dimethylacetamide and polyethylene glycol solution of the drug that is diluted into an aqueous lipid emulsion prior to use. The formulation is effective as a parenteral drug against taxane sensitive tumors.

L'invention concerne une préparation stable et efficace d'un analogue de taxane, de préférence un paclitaxel. La préparation comprend une solution de diméthylacétamide et de polyéthylène glycol sous la forme du médicament qu'on dilue dans une émulsion lipide de type aqueux avant absorption. La formulation est efficace comme médicament parentéral contre des tumeurs sensibles au taxane.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Parenteral paclitaxel in a stable non-toxic formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Parenteral paclitaxel in a stable non-toxic formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parenteral paclitaxel in a stable non-toxic formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1388117

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.